Beta blockade during and after myocardial infarction: an overview of the randomized trials (Q34557544)

3 August 2017

Beta blockade during and after myocardial infarction: an overview of the randomized trials (English)

1 reference

3 August 2017

myocardial infarction

1 reference

Yusuf S

1

1 reference

3 August 2017

Peto R

2

1 reference

3 August 2017

Lewis J

3

1 reference

3 August 2017

Collins R

4

1 reference

3 August 2017

Sleight P

5

1 reference

3 August 2017

1 March 1985

1 reference

Progress in Cardiovascular Diseases

3 August 2017

1 reference

3 August 2017

27

1 reference

3 August 2017

335-371

1 reference

3 August 2017

5

1 reference

Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Natural history of acute coronary heart attacks. A community study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Incidence and presentation of myocardial infarction in an English community

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Coronary heart-attacks in East London

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Estimation of Infarct Size in Man and its Relation to Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Relation of cardiac complications to SGOT level in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Myocardial Changes Associated with Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Factors influencing infarct size following experimental coronary artery occlusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of acute anemia on experimental myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Plasma Catecholamines and Carbohydrate Metabolism in Patients with Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of propranolol on regional myocardial blood flow in acute ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Prolonged protective effect of propranolol on hypoxic heart muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

A possible role of noradrenaline in the development of myocardial infarction: an experimental study in the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

The effect of propranolol on microvascular injury in acute myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects of ventricular function in the normal and ischaemic heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Treatment of acute myocardial infarction with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Absence of prophylactic effect of propranolol in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Trial of propranolol in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

An early intervention secondary prevention study with oxprenolol following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of atenolol on recovery of the electrocardiographic signs of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Beta-adrenergic blockade and cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Reduction of enzyme levels by propranolol after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Protective effect of propranolol in threatened myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effects of acebutolol on myocardial infarct extension: a randomized electrocardiographic, enzymatic and angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Early intravenous beta-blockade in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect of very early intervention with metoprolol on myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Very early intervention with metoprolol in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Letter: Reduction of sudden Deaths after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

A long-term prevention study with oxprenolol in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Controlled trial of sotalol for one year after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Variability of electrocardiographic and enzyme evolution of myocardial infarction in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Initiation of ventricular fibrillation outside hospital in patients with acute ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Heart rate and ectopic prematurity in relation to sustained ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Plasma propranolol concentration in patients with angina and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Solid angle theory and the electrocardiogram: Physiologic and quantitative interpretations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

The relationship between enzymatic and histologic estimates of the extent of myocardial infarction in conscious dogs with permanent coronary occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Natural history and evaluation of Q waves during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Acute myocardial infarction. Evaluation of praecordial ST segment mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Failure of ST segment elevation to predict severity of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Propranolol during the evolution and subsequent ten days of myocardial infarction in man: Hemodynamic, initial cardiac energetic, and neurohumoral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

A comparative study of cardioselective beta-blockade and diazepam in patients wtih acute myocardial infarction and tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Should every survivor of a heart attack be given a beta-blocker?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2885%2980003-7

7 January 2021

10.1016/S0033-0620(85)80003-7

Identifiers

DOI

1 reference

3 August 2017

1 reference